0 Комментарии
0 Поделились
462 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Breakthroughs in Drug Delivery and Precision Medicine Drive the Global Nanomedicine MarketExecutive Summary Nanomedicine Market Size and Share Forecast The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period The comprehensive market information and data of the Nanomedicine report will surely grow business and improve...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Charcot-Marie-Tooth Disease Market Size Projected to Reach USD 5.96 Billion by 2032The global Charcot-Marie-Tooth Disease Market focuses on the management and development of therapies for CMT, which represents a group of inherited neurological disorders that damage the peripheral nerves, leading to muscle weakness, loss of sensation, and physical impairment, predominantly in the feet, legs, hands, and arms. Currently, the market is characterized primarily by supportive and...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Nanomedicine Market Revolutionizes Healthcare with Targeted Drug Delivery InnovationsExecutive Summary Nanomedicine Market Size and Share Forecast CAGR The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period The comprehensive market information and data of the Nanomedicine report will surely grow business and...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Middle East and Asia Pacific Antibody Drugs Market Size Projected to Reach USD 175.72 Billion by 2032The Middle East and Asia Pacific Antibody Drugs Market comprises the sales, distribution, and consumption of therapeutic antibodies, which are highly specific proteins designed to target disease-causing agents, such as cancer cells or inflammatory proteins. These drugs, primarily Monoclonal Antibodies (mAbs), are central to the field of targeted therapy and are increasingly replacing...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр